Laurence Chu, MD
Otolaryngology · Austin, TXNPI 1902854680
Payments from drug & device makers
Across 3,432 payments — averaging $10,911 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$18.7M
- Pfizer$14.1M
- Novavax Inc$1.6M
- Sanofi Pasteur Inc.$1.1M
- Janssen Research & Development, LLC$783K
- GSK$489K
- plus $699K from 11 others
Across 11 payments — averaging $992.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$8K
- Sanofi Pasteur Inc.$2K
- Novavax Inc$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 2,339 | $18,703,452 |
| Pfizer | 631 | $14,073,557 |
| Novavax Inc | 111 | $1,585,711 |
| Sanofi Pasteur Inc. | 32 | $1,111,173 |
| Janssen Research & Development, LLC | 59 | $783,089 |
| GSK | 148 | $489,073 |
| Merck | 17 | $389,243 |
| Seqirus USA Inc | 20 | $137,096 |
| Astrazeneca UK Limited | 5 | $81,108 |
| AstraZeneca | 1 | $35,400 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $33,816 |
| Eisai Inc. | 14 | $21,777 |
| Sanofi | 20 | $281 |
| Regeneron Healthcare Solutions, Inc. | 2 | $147 |
| Stryker | 1 | $39 |
| Acclarent, Inc | 1 | $15 |
| Intersect ENT, Inc. | 1 | $15 |
How this compares
$37,444,989 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in Austin
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Chad McDuffieFrisco$1.5M
- Ian AlexanderBoerne$999K
- Stephen LaiHouston$968K
- Benjamin CilentoSpring$963K
- Amber LuongHouston$793K
- Jeffrey RosenbloomSan Antonio$720K
- Masayoshi TakashimaHouston$644K
- Marc DeanFort Worth$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.